CardioLync

Platform for Interpreting, Reporting, and Engaging with Patients

Health Tech & Life Sciences
Non Active, Nov 2022 ceased to operate
Pre-Funding Bet Shemesh, Israel Founded 2016
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2016
Headcount
1-10
HQ
Bet Shemesh, Israel
Sector
Health Tech & Life Sciences

About

CardioLync provides a platform for interpreting cardiovascular studies, reporting, and patient management of their cardiac history. With CardioLync's technology and easy-to-use interface, clinical data is moved seamlessly and securely so that clinicians can read and interpret diagnostic studies at their convenience and patients can access their imaging history anywhere.

Q&A

What is CardioLync's primary business?
CardioLync provides a platform for interpreting cardiovascular studies, reporting, and patient management of their cardiac history, facilitating seamless and secure clinical data movement.
Where is CardioLync headquartered?
CardioLync is headquartered in Bet Shemesh, Jerusalem District, Israel.
When was CardioLync founded?
CardioLync was founded in January 2016.
What is the current status of CardioLync?
CardioLync is currently inactive, having ceased operations in November 2022.
What is CardioLync's employee count?
CardioLync has 1-10 employees.
Who are the founders of CardioLync?
The founders of CardioLync are Jeremy Kagan, who serves as Founder & CEO, and Jacob Levy, MD FACC, who is the Chief Medical Officer.
What is CardioLync's primary sector?
CardioLync's primary sector is Health Tech & Life Sciences.
What is CardioLync's current funding stage?
CardioLync is currently in the Pre-Funding stage.

Team · 2

Founder · Founder & CEO
LinkedIn ↗
Founder · Chief Medical Officer
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareClinical WorkflowPatient Engagement
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesPharmaceuticals
Business model
B2B2CB2B

Highlights

Verified

Tags

diagnosticsclinical-workflowmedical-dataschedulinghealthcare-providersimagingdigital-therapeuticscardiologysurgerynon-invasivedigital-healthcareweb-platformsoftware-applicationsdata-analyticsradiologycardiovascularmhealthcross-platformheart-diseasesmonitoringmedical-technologiestreatmentspatientspharma-companiestelehealthtelematicstelemedicinehospitalsdoctors
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)